These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances. Rahman MA; Dash R; Sohag AAM; Alam M; Rhim H; Ha H; Moon IS; Uddin MJ; Hannan MA Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33804766 [TBL] [Abstract][Full Text] [Related]
3. Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer's Disease. Arora R; Babbar R; Dabra A; Chopra B; Deswal G; Grewal AS Cent Nerv Syst Agents Med Chem; 2024; 24(2):166-181. PubMed ID: 38305396 [TBL] [Abstract][Full Text] [Related]
4. New Drugs from Marine Organisms in Alzheimer's Disease. Russo P; Kisialiou A; Lamonaca P; Moroni R; Prinzi G; Fini M Mar Drugs; 2015 Dec; 14(1):5. PubMed ID: 26712769 [TBL] [Abstract][Full Text] [Related]
5. Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer's Disease. Olasehinde TA; Olaniran AO; Okoh AI Mar Drugs; 2019 Oct; 17(11):. PubMed ID: 31731422 [TBL] [Abstract][Full Text] [Related]
6. Role of natural products for the treatment of Alzheimer's disease. Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057 [TBL] [Abstract][Full Text] [Related]
7. Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease. Kwon Y Exp Gerontol; 2017 Sep; 95():39-43. PubMed ID: 28528007 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties. Siddiqui A; Shah Z; Jahan RN; Othman I; Kumari Y Biomed Pharmacother; 2021 Dec; 144():112250. PubMed ID: 34607104 [TBL] [Abstract][Full Text] [Related]
10. Salvia miltiorrhiza: A source for anti-Alzheimer's disease drugs. Zhang XZ; Qian SS; Zhang YJ; Wang RQ Pharm Biol; 2016; 54(1):18-24. PubMed ID: 25857808 [TBL] [Abstract][Full Text] [Related]
11. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion. Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568 [TBL] [Abstract][Full Text] [Related]
12. Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders. Catanesi M; Caioni G; Castelli V; Benedetti E; d'Angelo M; Cimini A Mar Drugs; 2021 Jan; 19(1):. PubMed ID: 33430021 [TBL] [Abstract][Full Text] [Related]
13. Marine-Derived Compounds with Anti-Alzheimer's Disease Activities. Hafez Ghoran S; Kijjoa A Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436249 [TBL] [Abstract][Full Text] [Related]
14. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells. Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698 [TBL] [Abstract][Full Text] [Related]
15. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms. Choi DY; Choi H Arch Pharm Res; 2015 Feb; 38(2):139-70. PubMed ID: 25348867 [TBL] [Abstract][Full Text] [Related]
16. Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer's Disease: A Review. Lee JY; Wong CY; Koh RY; Lim CL; Kok YY; Chye SM Yale J Biol Med; 2024 Jun; 97(2):205-224. PubMed ID: 38947104 [TBL] [Abstract][Full Text] [Related]
17. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease. Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757 [TBL] [Abstract][Full Text] [Related]
18. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies. Hölscher C Rev Neurosci; 2005; 16(3):181-212. PubMed ID: 16323560 [TBL] [Abstract][Full Text] [Related]
19. Exploitation of Marine Molecules to Manage Alzheimer's Disease. Silva M; Seijas P; Otero P Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34203244 [TBL] [Abstract][Full Text] [Related]
20. The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease. Karl T; Garner B; Cheng D Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):142-160. PubMed ID: 27471947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]